Halal Pharmaceuticals Become a New Hub for Muslim World Health
The halal pharmaceutical industry in Muslim-majority countries is undergoing a huge transformation, not just focusing on adhering to halal standards but also striving for self-reliance in the global health sector. This shift is supported by increased production capacity, technological innovation, and international cooperation.
The State of the Global Islamic Economy 2025/2026 report notes that Muslim pharmaceutical spending reached 112 billion US dollars in 2024, up 4.3 percent, and is projected to hit 146 billion US dollars by 2029. This is driven by demand for halal pharmaceutical products and consumer awareness about the safety of health products.
Muslim countries are integrating modern technology like artificial intelligence in drug development, as well as evidence-based traditional medicine. Cooperation among nations under the OIC is strengthened through regulatory harmonization and strategic partnerships for long-term health sovereignty.
Innovation is the main driver, with a focus on disease prevention, research, and immunization. Halal pharmaceuticals are now becoming a vital pillar of a global health ecosystem that is inclusive, sustainable, and grounded in ethics and consumer trust.
https://mozaik.inilah.com/hala